S )-(+)-épichlorohydrine, 98 %

Code: 540080-25g D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Used in the total synthesis of Macquarimicins and in the total synthesis of the macrolide RK-397.

Chiral building block in the enantioselective syntheses of...


en savoir plus

Votre prix
£59.50 25G

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Used in the total synthesis of Macquarimicins and in the total synthesis of the macrolide RK-397.

Chiral building block in the enantioselective syntheses of hydroxyisoxazolidines and (+)-cis-sylvaticin, a potential antitumor agent.

Used to synthesize inhibitors of fatty acid oxidation as potential metabolic modulators.

Legal Information

Manufactured under license by Sterling Pharma Solutions Limited, using Jacobsen HKR technology.

Packaging

5, 25 g in glass bottle

assay98%
autoignition temp.1421 °F
bp92-93 °C/360 mmHg (lit.)
density1.183 g/mL at 25 °C (lit.)
expl. lim.21 %
InChI keyBRLQWZUYTZBJKN-GSVOUGTGSA-N
InChI1S/C3H5ClO/c4-1-3-2-5-3/h3H,1-2H2/t3-/m1/s1
optical activity[α]20/D +35°, c = 1 in methanol
optical purityee: 97% (GLC)
Quality Level200
refractive indexn20/D 1.438 (lit.)
SMILES stringClC[C@@H]1CO1
vapor density3.2 (vs air)
vapor pressure12.5 mmHg ( 20 °C)
Code
Description
Unité de vente
Prix annoncé
Qté
540080-5G
Unité:5G
Prix annoncé: £37.90
Source:Prix annoncé
Cas Number67843-74-7
Hazard Class6.1
Un Number2023
Pack GroupII
Ce produit répond aux critères suivants: